Globus Medical Current Ratio 2010-2022 | GMED

Current and historical current ratio for Globus Medical (GMED) from 2010 to 2022. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Globus Medical current ratio for the three months ending June 30, 2022 was 6.10.
Globus Medical Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2022-06-30 $0.89B $0.15B 6.10
2022-03-31 $0.92B $0.14B 6.48
2021-12-31 $0.87B $0.14B 6.17
2021-09-30 $0.98B $0.12B 8.00
2021-06-30 $0.89B $0.13B 6.86
2021-03-31 $0.81B $0.12B 6.59
2020-12-31 $0.82B $0.12B 6.80
2020-09-30 $0.81B $0.10B 8.12
2020-06-30 $0.70B $0.11B 6.57
2020-03-31 $0.64B $0.10B 6.55
2019-12-31 $0.69B $0.11B 6.17
2019-09-30 $0.64B $0.10B 6.71
2019-06-30 $0.58B $0.08B 6.94
2019-03-31 $0.62B $0.08B 7.77
2018-12-31 $0.63B $0.10B 6.56
2018-09-30 $0.65B $0.08B 7.91
2018-06-30 $0.63B $0.08B 7.89
2018-03-31 $0.62B $0.08B 7.45
2017-12-31 $0.62B $0.09B 6.67
2017-09-30 $0.56B $0.08B 7.52
2017-06-30 $0.54B $0.07B 7.75
2017-03-31 $0.54B $0.08B 7.18
2016-12-31 $0.51B $0.08B 6.43
2016-09-30 $0.48B $0.07B 7.27
2016-06-30 $0.54B $0.07B 7.62
2016-03-31 $0.52B $0.07B 7.13
2015-12-31 $0.55B $0.08B 6.59
2015-09-30 $0.51B $0.09B 5.36
2015-06-30 $0.46B $0.09B 4.96
2015-03-31 $0.46B $0.09B 4.88
2014-12-31 $0.47B $0.09B 5.26
2014-09-30 $0.49B $0.07B 6.66
2014-06-30 $0.47B $0.07B 7.08
2014-03-31 $0.46B $0.07B 6.36
2013-12-31 $0.42B $0.07B 6.14
2013-09-30 $0.39B $0.06B 6.58
2013-06-30 $0.34B $0.06B 5.97
2013-03-31 $0.32B $0.05B 7.14
2012-12-31 $0.36B $0.04B 9.12
2012-09-30 $0.33B $0.03B 9.79
2012-06-30 $0.29B $0.03B 10.12
2012-03-31 $0.28B $0.04B 7.84
2011-12-31 $0.26B $0.03B 8.84
2011-09-30 $0.00B 0.00
2011-06-30 $0.00B 0.00
2011-03-31 $0.00B 0.00
2010-12-31 $0.22B $0.03B 6.90
2009-12-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $5.928B $0.958B
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $198.711B 20.24
Edwards Lifesciences (EW) United States $51.226B 36.24
Alcon (ALC) Switzerland $28.513B 24.14
STERIS (STE) Ireland $16.630B 20.66
Teleflex (TFX) United States $9.450B 15.06
Fresenius Medical Care AG KGaA (FMS) Germany $8.228B 7.59
Penumbra (PEN) United States $7.184B 861.82
Glaukos (GKOS) United States $2.520B 0.00
Integer Holdings (ITGR) United States $2.061B 16.12
Nevro (NVRO) United States $1.649B 0.00
Paragon 28 (FNA) United States $1.368B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.031B 15.78
Artivion (AORT) United States $0.558B 53.23